An Integrated Disease/Pharmacokinetic/Pharmacodynamic Model Suggests Improved Interleukin-21 Regimens Validated Prospectively for Mouse Solid Cancers.
Moran ElishmereniYuri KheifetzHenrik SøndergaardRune Viig OvergaardZvia AgurPublished in: PLoS Comput. Biol. (2011)